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James L. Cox, MD, St. Louis, MoPMCongenital HeartDisease (CHD)
1387 Total anomalous pulmonary venous connection: Results of surgical repair of 100
patients at a single institution
Angela M. Kelle, BS, Carl L. Backer, MD, Jeffrey G. Gossett, MD, Sunjay Kaushal, MD, PhD, and
Constantine Mavroudis, MD, Chicago, Ill, and Cleveland, Ohio
One hundred patients with total anomalous pulmonary venous connection are reviewed.
Mortality and reoperations for pulmonary vein stenosis are higher in patients with single-
ventricle anatomy.ET
/B
S1395 Repair of the bicuspid aortic valve: A viable alternative to replacement with
a bioprosthesis
Elena Ashikhmina, MD, PhD, Thoralf M. Sundt III, MD, Joseph A. Dearani, MD, Heidi M. Connolly,TXMD, Zhuo Li, MS, and Hartzell V. Schaff, MD, Rochester, Minn
From 1984 through 2007, 108 patients underwent bicuspid aortic valve repair in our clinic. Freedom
from valve replacement was 96%, 89%, and 49% at 1, 5, and 10 years, respectively. Comparison
among 81 matched patients undergoing repair or placement of an aortic valve bioprosthesis showed
no difference in 10-year survival or freedom from reoperation between groups.(continued on page 14A)
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TX1402 Glutaraldehyde treatment of allograft tissue decreases allosensitization after the
Norwood procedure
Bryce J. Laing, MD, David B. Ross, MD, Steven R. Meyer, MD, PhD, Patricia Campbell, MBChB,
Anne M. Halpin, MSc, Lori J. West, MD, DPhil, and Ivan M. Rebeyka, MD, Edmonton, Alberta,
Canada
Infants born with hypoplastic left heart syndrome often receive allograft tissue during aortic
reconstruction. This allograft tissue is a tremendous source of allosensitization that complicates future
cardiac transplantation. Treating the allograft tissue with glutaraldehyde before implantation prevents
this allosensitization response.
1409 Minimally invasive perventricular device closure of perimembranous
ventricular septal defect without cardiopulmonary bypass: Multicenter
experience and mid-term follow-up
Quansheng Xing, MD, Silin Pan, MS, Qi An, MD, Zewei Zhang, MD, Jianhua Li, MD, Feng Li, MD,
Qin Wu, MS, and Zhongyun Zhuang, MS, Qingdao, Chengdu, Hangzhou, and Shanghai, China
We retrospectively reviewed 408 patients in 4 cardiac centers who underwent minimally invasive
perventricular device closure of perimembranous ventricular septal defect without cardiopulmonary
bypass under transesophageal echocardiography guidance and summarized the multicenter
experiences and follow-up results.
1416 Pulmonary autograft valve explants show typical degeneration
Aart Mookhoek, MSc, Emile de Heer, PhD, Ad J. J. C. Bogers, MD, PhD, Johanna J. M. Takkenberg,
MD, PhD, and Paul H. Schoof, MD, PhD, Leiden and Rotterdam, The Netherlands
We evaluated histologic changes in explanted pulmonary autograft valves. Fibrous hyperplasia of the
ventricularis was a consistent finding, and its cellular and extracellular matrix characteristics suggest
it to be the result of sustained remodeling. The architectural changes might cause failure of the
pulmonary autograft valve in the long-term.
1420 Modified Ross operation with reinforcement of the pulmonary autograft:
Six-year results
Francis Juthier, MD, PhD, Carlo Banfi, MD, PhD, FCCP, Andre´ Vincentelli, MD, PhD,
Pierre-Vladimir Ennezat, MD, PhD, Thierry Le Tourneau, MD, PhD, Claire Pinc¸on, PhD, and
Alain Prat, MD, Lille, France
We report the midterm results of pulmonary autograft reinforcement with a Valsalva Gelweave
Dacron tube. Since 2003, 12 patients have undergone this modified Ross procedure. No perioperative
deaths were observed. No significant autograft regurgitation or dilatation was recorded during 6 years
of follow-up.General Thoracic
Surgery (GTS)1424 Pneumonectomy is a valuable treatment option after neoadjuvant therapy for
stage III non–small-cell lung cancer
Walter Weder, MD, Ste´phane Collaud, MD, Wilfried E. E. Eberhardt, MD, Sven Hillinger, MD,Stefan Welter, MD, Rolf Stahel, MD, and Georgios Stamatis, MD, Zurich, Switzerland; and Essen
and Essen-Heidhausen, Germany
The combined results of pneumonectomy after neoadjuvant chemotherapy or chemoradiotherapy for
stage III NSCLC performed in 2 experienced centers demonstrated an operative mortality of 3% and
a 5-year survival rate of 38%. Despite conflicting results of large-scale phase III studies, this
procedure remains a valuable option for selected patients.(continued on page 16A)
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TX1431 Type B thymoma: Is prognosis predicted only by World Health Organization
classification?
Hong Kwan Kim, MD, Yong Soo Choi, MD, Jhingook Kim, MD, PhD, Young Mog Shim, MD, PhD,
Joungho Han, MD, PhD, and Kwhanmien Kim, MD, PhD, Seoul, Korea
Tumor recurrence was significantly associated with advanced Masaoka stage regardless of the WHO
subtype of type B thymomas. Given the heterogeneity of WHO type B thymomas, Masaoka stage
should always be considered when predicting prognosis and planning adjuvant treatment for patients
with type B thymomas.1436 Effects of head-up tilt on intrapulmonary shunt fraction and oxygenation
during 1-lung ventilation in the lateral decubitus position
Sung Yong Park, MD, Dae Hee Kim, MD, Jin Soo Kim, MD, PhD, Sung Soo Lee, MD, and
Yong Woo Hong, MD, PhD, Suwon, Korea
Hypoxemia is a common problem of 1-lung ventilation. The surgical position influences the shunt
and arterial oxygenation. Head-up tilt during 1-lung ventilation in the lateral decubitus position
caused a significant decrease in shunt and an increase in arterial oxygenation.1441 Impact of positive pleural lavage cytology on survival in patients having lung
resection for non–small-cell lung cancer: An international individual patient
data meta-analysis
International Pleural Lavage Cytology Collaborators
We conducted an 8763 individual patient data meta-analysis of the utility of pleural lavage cytology
before resection of non–small-cell lung cancer reporting a positive result as an independent predictor
of adverse survival and suggesting that it may be appropriate to upstage patients with positive results
by one T category.1447 A follow-up of integrated positron emission tomography/computed tomography
after curative resection of non–small-cell lung cancer in asymptomatic patients
Sukki Cho, MD, and Eung Bae Lee, MD, PhD, Daegu, Korea
There is no ideal surveillance strategy and the effectiveness of follow-up regimens is debatable after
curative resection of NSCLC. Integrated PET/CT can be used as a follow-up regimen for the early
detection of recurrence in asymptomatic patients with NSCLC.1452 Laparoscopic diaphragmatic plication for diaphragmatic paralysis and
eventration: An objective evaluation of short-term and midterm results
Shawn S. Groth, MD, Natasha M. Rueth, MD, Teri Kast, RN, Jonathan D’Cunha, MD, PhD,
Rosemary F. Kelly, MD, Michael A. Maddaus, MD, FACS, and Rafael S. Andrade, MD,
Minneapolis, Minn
We present the results of an objective evaluation of laparoscopic diaphragmatic plication for
symptomatic diaphragmatic paralysis or eventration. We found that laparoscopic diaphragmatic
plication results in significant improvements in quality of life and pulmonary function at short-term
and midterm follow-up.(continued on page 18A)
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TX1457 Is pulmonary function damaged by neoadjuvant lung cancer therapy?
A comprehensive serial time-trend analysis of pulmonary function after
induction radiochemotherapy plus surgery
S. Margaritora, MD, A. Cesario, MD, G. Cusumano, MD, S. Cafarotti, MD, G. M. Corbo, MD,
L. Ferri, MD, M. Ceppi, MD, E. Meacci, MD, S. Valente, MD, R. M. D’Angelillo, MD, P. Russo,
V. Porziella, MD, S. Bonassi, MD, F. Pasqua, MD, S. Sterzi, MD, and P. Granone, MD, Rome and
Genoa, Italy
The aim of this study was to carry out a comprehensive and serial analysis of pulmonary function after
induction chemoradiotherapy protocol for patients with locally advanced NSCLC. The induction
therapy damages lung function. Nevertheless, in the postoperative period we observed a partial
recovery of DLCO in the entire population and a positive trend of the spirometric parameters in the
younger population.Acquired Cardiovascular
Disease (ACD)1464 Staged repair significantly reduces paraplegia rate after extensive
thoracoabdominal aortic aneurysm repair
Christian D. Etz, MD, PhD, Stefano Zoli, MD, Christoph S. Mueller, MS, Carol A. Bodian, DrPH,Gabriele Di Luozzo, MD, Ricardo Lazala, MD, Konstadinos A. Plestis, MD, and Randall B. Griepp,
MD, New York, NY
This retrospective study compared extensive thoracoabdominal aneurysms repaired in a single stage
(55 patients) with those repaired in 2 stages (35 patients). No spinal cord injury was seen among
patients in the 2-stage group despite significantly (P 5 .001) more segmental arteries sacrificed,
versus a 15% rate of paraplegia and paraparesis in the single-stage group (P 5 .02).1473 Surgical management of secondary tricuspid valve regurgitation: Annulus,
commissure, or leaflet procedure?
Jose L. Navia, MD, Edward R. Nowicki, MD,MS, Eugene H. Blackstone, MD, Nicolas A. Brozzi, MD,
Daniel E. Nento, MD, Fernando A. Atik, MD, Jeevanantham Rajeswaran, MSc, A. Marc Gillinov,
MD, Lars G. Svensson, MD, PhD, and Bruce W. Lytle, MD, Cleveland, Ohio
Rigid prosthetic ring annuloplasty, standard or 3-dimensional, provides early and sustained reduction
of TR secondary to left-sided valve disease without need for an additional leaflet procedure.
However, results are imperfect, possibly because other anatomic levels (subvalvular, papillary
muscle, and right ventricular) contributing to its pathophysiology are unaddressed.1483 Echocardiographic approach to the decision-making process for tricuspid valve
repair
Farideh Roshanali, MD, Bahare Saidi, MD, Mohammad Hossein Mandegar, MD, Mohammad Ali
Yousefnia, MD, and Farshid Alaeddini, MD, Tehran, Iran
To reduce the high failure rate of tricuspid valve repair, patch augmentation was performed in
conjunction with the standard procedure in patients with a high tethering index. We showed that the
addition of this procedure in these selected groups was successful in reducing the rate of residual
tricuspid regurgitation.(continued on page 20A)
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TX1488 Safety and durability of mitral valve repair for anterior leaflet perforation
Basar Sareyyupoglu, MD, Hartzell V. Schaff, MD, Rakesh M. Suri, MD, DPhil, Heidi M. Connolly,
MD, Richard C. Daly, MD, and Thomas A. Orszulak, MD, Rochester, Minn
The outcome of mitral valve repair for anterior leaflet perforation was investigated. Patient survival
was 90% at 5 years, and only 1 (4%) patient required mitral valve reoperation after 7 years owing to
recurrent endocarditis. Mitral valve anterior leaflet perforation may be safely repaired with good
midterm survival and durability.
1494 Fifteen years of experience with ATS mechanical heart valve prostheses
Akira Sezai, MD, Mitsumasa Hata, MD, Tetsuya Niino, MD, Isamu Yoshitake, MD, Yuji Kasamaki,
MD, Atsushi Hirayama, MD, and Kazutomo Minami, MD, Tokyo, Japan
We present the results of 15 years of follow-up of patients who have undergone ATS valve
replacement. Few prosthetic valve–related complications were seen in this study, and the follow-up
results were favorable. Prosthetic valve noise is low, and this appears to be an excellent mechanical
valve from the QOL standpoint.
1501 Left ventricular flow patterns in healthy subjects and patients with prosthetic
mitral valves: An in vivo study using echocardiographic particle image
velocimetry
Re´ka Faludi, MD, Mariola Szulik, MD, Jan D’hooge, PhD, Paul Herijgers, MD, PhD,
Frank Rademakers, MD, PhD, Gianni Pedrizzetti, PhD, and Jens-Uwe Voigt, MD, PhD,
Leuven, Belgium, and Trieste, Italy
The new method of echocardiographic particle image velocimetry can describe and distinguish left
ventricular flow patterns in healthy hearts and in patients with different types of prosthetic mitral
valves. Energy dissipation caused by disturbed flow patterns can be estimated.
1511 Late outcomes after radial artery versus saphenous vein grafting during
reoperative coronary artery bypass surgery
Anoar Zacharias, MD, Thomas A. Schwann, MD, Christopher J. Riordan, MD, Samuel J. Durham,
MD, Aamir S. Shah, MD, Milo Engoren, MD, and Robert H. Habib, PhD, Toledo, Ohio
We studied 347 consecutive coronary artery bypass grafting (CABG) reoperations in which internal
thoracic artery grafts were frequently used during initial and repeat revascularization. Use of radial
artery as opposed to saphenous vein grafts at reoperation did not significantly improve hospital
outcomes but was associated with a substantial risk-adjusted late survival benefit (risk ratio, 0.58) that
was also confirmed in a propensity-matched comparison. This result is analogous to the late survival
benefit reported for radial artery use as a second arterial conduit in primary CABG operations.
1519 Transcatheter aortic valve implantation for high-risk patients with severe aortic
stenosis: A systematic review
Tristan D. Yan, BSc(Med), MBBS, PhD, Christopher Cao, BSc(Med), MBBS, Julie Martens-Nielsen,
MD, Ratnasari Padang, BSc(Med), MBBS, Martin Ng, MBBS, PhD, Michael P. Vallely, MBBS, PhD,
FRACS, and Paul G. Bannon, MBBS, PhD, FRACS, Sydney, Australia
The present systematic review objectively assessed the safety and clinical effectiveness of
transcatheter aortic valve implantation for patients with high surgical risk with severe aortic stenosis.
The procedure has a potential for serious complications. Although short-term efficacy based on
echocardiography measurements is good, there is little evidence on long-term outcomes.(continued on page 22A)
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TX1529 Baseline left ventricular function and surgical annular stiffening to predict
outcome and reverse left ventricular remodeling after undersized annuloplasty
for intermediate-degree ischemic mitral regurgitation
Marco Pocar, MD, PhD, Davide Passolunghi, MD, AndreaMoneta, MD, Alessandra DiMauro, MD,
Alda Bregasi, MD, Roberto Mattioli, MD, and Francesco Donatelli, MD, FETCS, Milan, Italy
Fifty-seven patients with ischemic mitral regurgitation underwent undersized annuloplasty with
different techniques and were followed up to 8.6 years. Mortality was 5%, whereas global and
regional wall motion were the strongest predictors of late death and adverse events. A stiffer repair
predicted earlier reverse ventricular remodeling.
1539 The effect of cardiac angiography timing, contrast media dose, and preoperative
renal function on acute renal failure after coronary artery bypass grafting
Benjamin Medalion, MD, Hilit Cohen, MD, Abid Assali, MD, Hana Vaknin Assa, MD, Ariel Farkash,
MD, Eitan Snir, MD, Erez Sharoni, MD, Philip Biderman, MD, Gai Milo, MD, Alexander Battler,
MD, Ran Kornowski, MD, and Eyal Porat, MD, Petach Tiqva, Israel
ARF developed in 13.6% of 395 consecutive patients who underwent CABG. Several risk factors
were identified for its development. In particular, low estimated creatinine clearance, high contrast
dose, and interval between angiography and surgery. If possible, CABG should be delayed for 5 days
in selected high-risk patients.
1545 Sex- and ethnic group–specific nationwide trends in the use of coronary artery
bypass grafting in the United States
Mohammad Reza Movahed, MD, PhD, Mehrtash Hashemzadeh, MS, Ali Khoynezhad, MD,
M. Mazen Jamal, MD, and Radhakrishnan Ramaraj, MD, Tucson, Ariz, Long Beach, Calif, and
Omaha, Neb
Use of coronary artery bypass grafting has decreased dramatically in recent years and is even lower
among female and ethnic minority patients. The decline may be related to significant advances in
percutaneous coronary interventions and improved medical treatment of atherosclerosis in the past 10
years.
1548 Early and midterm results of thoracic endovascular aortic repair of chronic
type B aortic dissection
Shang Dong Xu, MD, Fang Jiong Huang, MD, Jin Fei Yang, MD, Zhi Zhong Li, MD, Sheng Yang,
MD, Jia Hui Du, MD, and Zhao Guang Zhang, MD, Beijing, China
In early and midterm results, thoracic endovascular aortic repair was effective in the treatment of
chronic type B aortic dissection. Endoleak was themain cause of death during follow-up. Flexible and
tapered stent graft may be more suitable for aortic dissection. Results are likely to improve in the
future.Perioperative
Management (PM)1554 Endobronchial ultrasound increases the diagnostic yields of polymerase chain
reaction and smear for pulmonary tuberculosis
Shu-Min Lin, MD, Yung-Lun Ni, MD, Chih-Hsia Kuo, MD, Ting-Yu Lin, MD, Tsai-Yu Wang, MD,
Fu-Tsai Chung, MD, and Han-Pin Kuo, MD, PhD, Taipei, Taiwan
In patients with negative sputum acid-fast bacillus smear or no sputum production, the introduction of
endobronchial ultrasound increased the diagnostic yields for tuberculosis by bronchoscopy-related
procedures including the nucleic acid amplification tests, acid-fast bacillus smear, and
Mycobacterium tuberculosis culture from bronchoalveolar lavage fluid.(continued on page 24A)
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TX1561 The effectiveness of prestorage leukocyte-reduced red blood cell transfusion on
perioperative inflammatory response with a miniaturized biocompatible bypass
system
Kagami Miyaji, MD, PhD, Takashi Miyamoto, MD, PhD, Satoshi Kohira, CCCP, Kei-ichi Itatani,
MD, Takahiro Tomoyasu, MD, Hajime Sato, MD, PhD, and Kuniyoshi Ohara, MD, PhD,
Sagamihara and Tokyo, Japan
We studied the effectiveness of prestorage leukocyte-reduced red blood cell concentrates (RCC-LR)
in which the leukocytes were reduced soon after collection for perioperative inflammatory response.
RCC-LR transfusion is effective in reducing the inflammatory response compared with stored red
blood cell transfusion, resulting in improved clinical outcomes in neonates and small infants.
1568 The relationship between perioperative temperature and adverse outcomes
after off-pump coronary artery bypass graft surgery
Edward L. Hannan, PhD, Zaza Samadashvili, MD, Andrew Wechsler, MD, Desmond Jordan, MD,
Stephen J. Lahey, MD, Alfred T. Culliford, MD, Jeffrey P. Gold, MD, Robert S. D. Higgins, MD, and
Craig R. Smith, MD, Albany and New York, NY; Philadelphia, Pa; Toledo, Ohio; and Chicago, Ill
This study identifies significant predictors of hypothermia and hyperthermia among patients
undergoing off-pump CABG and demonstrates that patients with moderate to severe hypothermia
had significantly higher risk-adjusted in-hospital mortality than patients with normothermia and that
patients with mild hyperthermia had significantly higher mortality.Evolving Technology/
Basic Science (ET/BS)1576 Normokalemic adenosine–lidocaine cardioplegia: Importance of maintaining
a polarized myocardium for optimal arrest and reanimation
Kathryn L. Sloots, BSc (Hons), and Geoffrey P. Dobson, PhD, Townsville, Queensland, Australia
Adenosine–lidocaine (AL) cardioplegia was examined in the presence of 0.1, 3, 5.9, 10, and 16
mmol/L potassium (K1) during 1 and 2 hours’ arrest at 33C. AL cardioplegia demonstrated superior
arrest and recovery profiles when the membrane potential was maintained around the resting cell
voltage by using physiologic levels of K1.
1587 Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity
Justin D. Blasberg, MD, ChandraM. Goparaju, PhD, Harvey I. Pass, MD, and Jessica S. Donington,
MD, New York, NY
Osteopontin is a multifunctional phosphoprotein with an important but poorly understood role in
non–small-cell lung cancer pathogenesis. The role of the 3 human isoforms has not been previously
reported. We demonstrate that individual osteopontin isoforms have divergent effects on non–small-
cell lung cancer angiogenesis with associated changes in VEGF.
1594 Carbonmonoxide reduces pulmonary ischemia–reperfusion injury inminiature
swine
Hisashi Sahara, MD, Akira Shimizu, MD, PhD, Kentaro Setoyama, DVM, PhD, Masayoshi Okumi,
MD, PhD, Manei Oku, MD, Emma Samelson-Jones, MD, and Kazuhiko Yamada, MD, PhD,
Kagoshima, Japan
Exogenously administered CO has been shown to reduce ischemia–reperfusion injury (IRI) in murine
models. We established a clinically relevant porcine model of lung IRI and showed that the
perioperative inhalation of low-dose CO decreased IRI. This effect was mediated by the
downregulation of proinflammatory mediators.
(continued on page 26A)
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TX1602 Long-term follow-up, computed tomography, and computational fluid dynamics
of the Cabrol procedure
Joseph Knight, MS, Stephan Baumu¨ller, MD, Vartan Kurtcuoglu, PhD, MD, Marko Turina, MD,
Juraj Turina, MD, Ulrich Schurr, MD, Dimos Poulikakos, PhD, William Marshall, Jr, MD, and
Hatem Alkadhi, MD, Zurich, Switzerland, Tampa, Fla, and Boston, Mass
The Cabrol graft procedure describes the replacement of the ascending aorta with reimplantation of
the coronary arteries by interposition of a graft tube. We report on clinical long-term follow-up and
CT findings and performed blood flow simulations in the Cabrol grafts of 7 patients. We found low
blood flow rates particularly in the right as compared with the left Cabrol graft, correlating with
a higher incidence of graft occlusions.1609 Electron transport chain dysfunction in neonatal pressure-overload
hypertrophy precedes cardiomyocyte apoptosis independent of oxidative stress
Eric R. Griffiths, MD, Ingeborg Friehs, MD, Elisabeth Scherr, MD, Dimitrios Poutias, BS, Francis X.
McGowan, MD, and Pedro J. del Nido, MD, Boston, Mass
In neonatal pressure-overload LVH, ETC dysfunction characterized by decreased activity of ETC
complexes I and II worsens with ventricular decompensation. The impaired ETC function is
associated with decreased oxidative stress and activation of the mitochondrial apoptosis pathway.1618 A new instrument of suction support adapter system for epicardial
radiofrequency ablation
Shinichi Kadoya, MD, Go Watanabe, MD, Yoshinao Koshida, MD, Makoto Oda, MD, and Shojiro
Yamaguchi, MD, Kanazawa, Japan
We developed a suction support adapter with the aim of ensuring contact between the ablation
probe for epicardial ablation on the beating heart and the atrial wall to obtain transmural
coagulation. We evaluated the effectiveness of the adapter in electrophysiologic and
histopathologic procedures1623 Effect of pressure management during hypothermic selective cerebral perfusion
on cerebral hemodynamics and metabolism in pigs
Peter L. Haldenwang, MD, Justus T. Strauch, MD, Katharina Mu¨llem, Hannah Reiter, Oliver
Liakopoulos, MD, Ju¨rgen H. Fischer, MD, Hildegard Christ, and Thorsten Wahlers, MD, Cologne,
Germany
In this acute animal model, we evaluated the impact of perfusion pressure during selective cerebral
perfusion (SCP) on cerebral hemodynamics and the metabolic rate of oxygen. We simulated the
intraoperative situation of a short interval of HCA followed by an extended period of SCP and found
that high-pressure perfusion provides no benefit during long-term SCP when compared with mid- or
low-pressure perfusion. Higher cerebral blood flow during the initial 25 minutes of selective cerebral
perfusion leads to cerebral edema, with no benefit in the cerebral metabolic rate. These findings could
be highly relevant for different clinical strategies of perfusion.(continued on page 28A)
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Transplantation (TX)28A The Journal of Thoracic an1632 Infection after implantation of pulsatile mechanical circulatory
support devices
William L. Holman, MD, James K. Kirklin, MD, David C. Naftel, PhD, Robert L. Kormos, MD,
Patricia Desvign-Nickens, PhD, Margarita T. Camacho, MD, and Deborah D. Ascheim, MD,
Birmingham, Ala, Pittsburgh, Pa, Rockville, Md, Newark, NJ, and New York, NY
INTERMACS is a registry for MCSDs. This analysis of INTERMACS examined aspects of infection
adverse events after MCSD implant. Infection was a relatively common event within the first 3
months of implant and had an important adverse effect on survival.1637 Orthotopic vascularized right lung transplantation in the mouse
Wenjun Li, MD, Seiichiro Sugimoto, MD, PhD, Jiaming Lai, MD, G. Alexander Patterson, MD,
Andrew E. Gelman, PhD, Alexander S. Krupnick, MD, and Daniel Kreisel, MD, PhD, St Louis, Mo
Orthotopic left lung transplantation in the mouse, as recently developed by our laboratory, represents
a physiologic model for studies in transplantation biology. However, survival cannot be used as
a readout of graft function after left lung transplantation. Here, we report the development of a right
lung transplantation model in the mouse. Because right lung transplant recipients survive a left
pneumonectomy, this represents the first survival model of vascularized lung transplantation in the
mouse.1644 Persistent plasminogen activator inhibitor 1 gene expression in cardiac
transplant recipients with idiopathic dilated cardiomyopathy
Romana Scha¨fer, PhD, Katharina Krenn, MD, Matthias Gmeiner, MD, Dietmar Abraham, PhD, and
Seyedhossein Aharinejad, MD, PhD, Vienna, Austria
Plasminogen activator inhibitor 1 (PAI-1) levels were upregulated in myocardium of patients with
dilated cardiomyopathy (DCM), returned to control levels shortly after, and increased 24 weeks after
transplantation in myocardial biopsy specimens and sera. Pretransplantation and posttransplantation
sera of patients with DCM inhibited endothelial cell proliferation. PAI-1 might play a role in patients
with DCM undergoing cardiac transplantation.Brief Technique Reports 1652 Aortic root translocation with atrial switch: Another surgical option for
congenitally corrected transposition of the great arteries with isolated
pulmonary stenosis
Jae Gun Kwak, MD, Chang-Ha Lee, MD, Cheul Lee, MD, and Chun Soo Park, MD, Bucheon, Korea1654 Total aortic arch reconstruction with open placement of triple-branched stent
graft for acute type A dissection
Liang-Wan Chen, MD, Xiao-Fu Dai, MD, Gui-Can Zhang, MD, and Lin Lu, MD, Fuzhou, Fujian,
China1656 Redo in aortic homograft replacement: Transcatheter aortic valve as a valid
alternative to surgical replacement
Luca Dainese, MD, Melissa Fusari, MD, Piero Trabattoni, MD, and Paolo Biglioli, MD, Milan, Italy1658 Esmark elastoplasty for bleeding ventricular assist device outflow graft
associated with severe coagulopathy
Daniel J. DiBardino, MD, and Gregory S. Couper, MD, Boston, Mass(continued on page 30A)
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TX1659 Bronchoscopic transesophageal ultrasound–guided needle aspiration: An
alternative to the conventional transesophageal ultrasound–guided needle
aspiration technique
Masahide Oki, MD, Hideo Saka, MD, Chiyoe Kitagawa, MD, and Shinji Sato, MD, Nagoya and
Handa, Japan1661 Subxiphoid epicardial left ventricular pacing lead placement is feasible
Takeyoshi Ota, MD, PhD, David Schwartzman, MD, and Marco A. Zenati, MD, Pittsburgh, Pa1663 Sternal wire removal in pediatric patients: Wire versus cable sternotomy
closure
Lester C. Permut, MD, Justin Linam, MA, and Gordon A. Cohen, MD, PhD, Seattle, WashBrief Research Report 1665 Anticoagulation management during cardiopulmonary bypass: A survey of 54
North American institutions
Robert L. Lobato, MS, MD, George J. Despotis, MD, Jerrold H. Levy, MD, Linda J. Shore-Lesserson,
MD, Melvin O. Carlson, MSc, and Elliott Bennett-Guerrero, MD, Durham, NC, St. Louis, Mo,
Atlanta, Ga, Bronx, NY, and Framingham, MassOnline Only: Brief
Clinical Reportse117 Persistent fifth aortic arch
Raghavan Subramanyan, MD, DM, FRCPI, Anto Sahayaraj, MS, MCh, Prem Sekar, MRCP, and
Kothurathu M. Cherian, MS, FRACS, DSc (Hon), DSc (HC), Chennai, Indiae118 Treatment of deep sternal wound infections after coronary artery bypass
grafting by means of injection of platelet gel: An evolving technology
Erez Kachel, MD, Jeannie Callum, MD, Fuad Moussa, MD, Jenette Goldstein, MLT, and Stephen
Fremes, MD, Toronto, Ontario, Canadae120 Right ventricular reverse remodeling is possible despite twenty-one years of
absent tricuspid valve and severe right ventricular failure
Ramohan Marla, MD, Judy Fox, RNP, Raymond Q. Migrino, MD, Lee Biblo, MD, and R. Eric Lilly,
MD, Milwaukee, Wise122 Overcoming challenges: The use of minimal extracorporeal circulation in
Jehovah’s Witnesses undergoing cardiac surgery
Anil John, FRCS, Mark Bennett, MD, FRCA, Clinton Lloyd, FRCS (CTh), and Simon Allen, FRCS
(CTh), Plymouth, United Kingdome123 Use of the hybrid operating room for aortic valve replacement in a patient with
anomalous left circumflex artery
Ramanan Umakanthan, MD, Zachary E. Brewer, BS, John G. Byrne, MD, and Rashid M. Ahmad,
MD, Nashville, Tenne125 Successful pediatric single-lung transplantation with previous contralateral
pneumonectomy, using controlled ‘‘donation after cardiac death’’ lung, for
congenital pulmonary vein stenosis
Amit Pawale, MRCS, Michael McKean, MD, FRCPCH, John Dark, FRCS, and Asif Hasan,
FRCSCTh, Newcastle upon Tyne, United Kingdom(continued on page 32A)
d Cardiovascular Surgery c June 2010
Table of Contents (continued)














TXe127 Spontaneous rupture of the diaphragm: Case report and comprehensive review
of the world literature
Julian E. Losanoff, MD, David A. Edelman, MD, Walter A. Salwen, MD, and Marc D. Basson, MD,
PhD, MBA, Detroit and Lansing, Mich
e128 Aneurysm expansion caused by an intercostal type II endoleak after thoracic
endovascular aortic repair for secondary elephant trunk graft fixation
Atsushi Kitagawa, MD, Hitoshi Matsuda, MD, Kenji Okada, MD, and Yutaka Okita, MD,
Kobe, Japan
e131 Ebstein anomaly associated with double-orifice tricuspid valve
Keiichi Itatani, MD, Kagami Miyaji, MD, PhD, Nobuyuki Inoue, MD, and Kuniyoshi Ohara, MD,
PhD, Kanagawa, Japan
e133 Right ventricular approach for securing the aortic homograft to the
interventricular septum in bacterial endocarditis
Morteza Tavakkoli Hosseini, MD, Antonios Kourliouros, MRCS, and Mazin Sarsam, FRCS, London,
United Kingdom
e135 Repair of tetralogy of Fallot after the regression of multiple rhabdomyomas in
a patient with tuberous sclerosis
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